COVID-19 Vaccine Providers Newsletter 03.23.2022


  • FDA Safety Communication: Use and Store At-Home COVID-19 Tests Properly to Avoid Potential Harm
    • On March 18, 2022, the U.S Food and Drug Administration (FDA) released a safety communication about the proper use and storage of at-home Covid-19 test materials. As noted in the communication, FDA has received reports of injuries caused by incorrect use of at-home test components. Reports include people accidentally using the small bottle of test reagent as eye drops, and people placing the nasal swabs into the liquid solution before swabbing their nose.
    • FDA is alerting people that there is a potential for harm if FDA authorized at-home COVID-19 tests are not used according to the manufacturer’s test instructions. The FDA is also reminding people to keep the tests out of reach from children and pets.
    • FDA has also provided recommendations to promote the safe use of at-home COVID-19 tests.
  • Please take 5 minutes to complete this anonymous survey conducted by ImmunizeVA and is designed to get your current thoughts and opinions  regarding receiving the COVID-19 vaccine and recommending it to your patients. You may exit out of the survey at any time.
    • The survey is divided into three sections:
      • Demographic questions about you and your profession
      • Questions about your thoughts, attitudes, and concerns regarding receiving the COVID-19 vaccine
      • Questions about your thoughts, attitudes, and concerns regarding recommending the COVID-19 vaccine.
    • If you have any questions about the survey, please email us at
  • Pfizer Purple Cap Inventory Update
    • We continue to see a reduction of Pfizer Purple Cap in the field and appreciate your efforts to reduce this inventory.
    • Please use the Pfizer Purple Cap before ordering the Gray Cap, when possible, and remember to keep your inventory of Purple and Gray Caps separate to avoid any confusion regarding diluent (Purple Cap uses diluent and Gray Cap does not).
  • For questions about VaxMaX and its functionality, please visit the VaxMaX Help websitewhich includes reference guides and tutorial videos.

Best Practice Spotlight

Upcoming Events

  • On Wednesday, March 30 at 12 pm, VDH's Healthcare-Associated Infections & Antimicrobial Resistance Program will host an infection prevention lunch and learn about Healthcare-Associated Infections Reporting and the National Healthcare Safety Network. To register, see the registration link. Questions on this topic are welcome before the webinar -- please email them to
  • FDA has announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wednesday, April 6, from 8:30 am to 5 pm to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants. No vote is planned at this meeting and there will not be discussion of any product-specific applications. The meeting will be livestreamed for the public.
  • The Virginia Department of Health Office of Emergency Preparedness partnered with the Virginia Department of Behavioral Health & Development Services, and Virginia Hospital & Healthcare Association to conduct a virtual Community Based Emergency Response Seminar (CBERS) in April 2022. This year’s topic will be Mental Health Wellness and the Rippling Effects of COVID-19. Please join us as we discussed the different mental health issues that can affect us as we tackle responding and caring for others during this pandemic. Participants will learn about the various types of stress caused by providing care to others during COVID, the difference between burnout and compassion fatigue, self-care, and coping strategies.

Helpful Resources


  • Updated: Vaccination FAQs: A new FAQ addresses revaccination for certain individuals who received cancer chemotherapy or radiation. Updated FAQs involve the following topics:
    • status of vaccines for younger children
    • studies on breakthrough cases and further transmission of COVID-19
    • FAQs for healthcare providers who want additional information
    • studies on vaccine effectiveness in children and adolescents.
  • Updated: On the Isolation and Quarantine Calculator website under Step 1. Isolate and monitor your symptoms, added wording that people at higher risk of severe COVID-19 should contact their healthcare provider to see if they are eligible for treatment. 

Health Resources & Services Administration (HRSA)

Information about the COVID-19 vaccination program is changing frequently. This newsletter will offer regular updates to providers who have submitted an intent to vaccinate or signed the CDC provider agreement within Virginia.

VDH COVID-19 Vaccination Response: Healthcare Professionals Website